Cargando…

Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131

BACKGROUND AND AIM: This study aimed at determining whether there is a risk regarding the development of second primary malignancies after patient exposure to the low and medium radioiodine activity used during the treatment of differentiated thyroid cancers (DTC). METHODS: Second primary malignanci...

Descripción completa

Detalles Bibliográficos
Autores principales:	PICIU, DOINA, PESTEAN, CLAUDIU, BARBUS, ELENA, LARG, MARIA IULIA, PICIU, ANDRA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iuliu Hatieganu University of Medicine and Pharmacy 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990434/ https://www.ncbi.nlm.nih.gov/pubmed/27547058 http://dx.doi.org/10.15386/cjmed-636

Ejemplares similares

Psychological impact of (131)I radioprotection measures on thyroid cancer patients
por: BARBUS, ELENA, et al.
Publicado: (2018)

Quality of life in thyroid cancer patients: a literature review
por: BÃRBUŞ, ELENA, et al.
Publicado: (2017)

Primary hyperparathyroidism-jaw tumor syndrome: a confusing and forgotten diagnosis
por: PICIU, DOINA, et al.
Publicado: (2016)

Sentinel lymph node scintigraphy in cutaneous melanoma using a planar calibration phantom filled with Tc-99m pertechnetate solution for body contouring
por: PEŞTEAN, CLAUDIU, et al.
Publicado: (2016)

Radiation induced thyroid carcinoma in Romania – effects of the Chernobyl fallout, a systematic review of observational studies
por: GÁBORA, KATALIN, et al.
Publicado: (2018)

Evaluation of Malignancy Risk in 18F-FDG PET/CT Thyroid Incidentalomas
por: Larg, Maria-Iulia, et al.
Publicado: (2019)

Correlation between F18-FDG PET/CT Imaging and BRAF V600E Genetic Mutation for the Early Assessment of Treatment Response in Papillary Thyroid Cancers
por: Piciu, Andra, et al.
Publicado: (2020)

Mazabraud’s syndrome and thyroid cancer, a very rare and confusing association: a case report
por: Piciu, Doina, et al.
Publicado: (2015)

Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer Can Impair Titanium Dental Implants: An In Vitro Analysis
por: Piciu, Doina, et al.
Publicado: (2023)

Investigation of thyroid nodules in the female population in Cyprus and in Romania
por: PICIU, ANDRA, et al.
Publicado: (2015)

Circulating tumor cells in thyroid carcinoma - the prognostic role of this biomarker. Review of the literature
por: BĂDULESCU, IULIAN CLAUDIU, et al.
Publicado: (2017)

Left Supraclavicular Lymph Node Metastasis from Ovarian Cancer Associated with Papillary Thyroid Microcarcinoma, a Confusing Pathology-Essential Role of Functional Imaging
por: Piciu, Doina, et al.
Publicado: (2020)

Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study
por: Mester, Alexandru, et al.
Publicado: (2020)

The Side Effects of Therapeutic Radioiodine-131 on the Structure of Enamel and Dentin in Permanent Human Teeth
por: Mester, Alexandru, et al.
Publicado: (2021)

F-18 FDG-PET-CT in the Diagnostic of a Late Medullary Thyroid Carcinoma Recurrence in a Patient with Follicular-Papillary Thyroid Cancer
por: Piciu, Doina, et al.
Publicado: (2014)

Thyroid carcinoma and primary amenorrhea due to Mayer-Rokitansky-Küster-Hauser syndrome: a case report
por: Piciu, Doina, et al.
Publicado: (2012)

Association of Parathyroid and Differentiated Thyroid Carcinomas: A Narrative Up-To-Date Review of the Literature
por: Simescu, Razvan, et al.
Publicado: (2022)

Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience
por: Almasan, Iulia, et al.
Publicado: (2023)

Differentiated Thyroid Cancer in Children in the Last 20 Years: A Regional Study in Romania
por: Ștefan, Andreea-Ioana, et al.
Publicado: (2020)

Thyroid Microcarcinoma in Pediatric Population in Romania
por: Stefan, Andreea-Ioana, et al.
Publicado: (2021)

Post-Treatment Thyroid Diseases in Children with Brain Tumors: A Single-Center Experience at “Prof. Dr. Ion Chiricuță” Institute of Oncology, Cluj-Napoca
por: Cosnarovici, Maria Margareta, et al.
Publicado: (2020)

Triple Metachronous Malignancies with Thyroid Involvement: A Brief Overview of Five Case Reports over 20 Years of Institutional Experience
por: Marius-Ioan, Bădan, et al.
Publicado: (2020)

MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020
por: Hitu, Liviu, et al.
Publicado: (2020)

Highly aggressive pathology of non-functional parathyroid carcinoma
por: Piciu, Doina, et al.
Publicado: (2013)

Asymptomatic COVID–19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring
por: Piciu, Andra, et al.
Publicado: (2021)

Thyroid carcinoma associated with other primary neoplasms, a single center study
por: Gabora, Katalin, et al.
Publicado: (2022)

Human Exposures to Bisphenol A, Bisphenol F and Chlorinated Bisphenol A Derivatives and Thyroid Function
por: Andrianou, Xanthi D., et al.
Publicado: (2016)

Rationale for therapeutic decision-making in locally advanced and metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer, starting from a clinical case
por: Silaghi, Cristina Alina, et al.
Publicado: (2021)

A Comparative Study between 18F-FDG PET/CT and Conventional Imaging in the Evaluation of Progressive Disease and Recurrence in Ovarian Carcinoma
por: Rusu, George, et al.
Publicado: (2021)

Diagnostic Performance of F18-FDG PET/CT in Male Breast Cancers Patients
por: Piciu, Andra, et al.
Publicado: (2021)

Total Tumor Diameter and Unilateral Multifocality as Independent Predictor Factors for Metastatic Papillary Thyroid Microcarcinoma
por: Hîțu, Liviu, et al.
Publicado: (2021)

Challenges of thyroid cancer management in amiodarone-treated patients: a case report
por: PETRULEA, MIRELA SANDA, et al.
Publicado: (2015)

Pediatric Thyroid Cancer in Europe: An Overdiagnosed Condition? A Literature Review
por: Stefan, Andreea-Ioana, et al.
Publicado: (2020)

Is radioactive iodine- ( 131 ) treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
por: de Souza, Marcelo Cruzick, et al.
Publicado: (2015)

Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
por: Ravichandran, R, et al.
Publicado: (2010)

(131)I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine
por: Brudecki, K., et al.
Publicado: (2020)

Thyroid Cancer Diagnostics Related to Occupational and Environmental Risk Factors: An Integrated Risk Assessment Approach
por: Berinde, Gabriela Maria, et al.
Publicado: (2022)

Transient cytotoxicity of (131)I beta radiation in hyperthyroid patients treated with radioactive iodine
por: Sundaram, P. Shanmuga, et al.
Publicado: (2011)

Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer
por: Saftencu, Mihai, et al.
Publicado: (2019)

DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jdu3barn22ph5fjflp48oar839